News

Evaluation of Amazon.com's Recent Options Trading Trends

Evaluation of Amazon.com's Recent Options Trading Trends

Recent Movements in Amazon.com's Options Market

In the dynamic landscape of financial markets, a notable shift has been observed among the major players when it comes to Amazon.com. Recent analysis indicates that a significant bearish trend is taking hold. The review of options history for Amazon.com (NASDAQ: AMZN) has identified an impressive 43 unusual trades, signaling a cautionary stance among investors.

Insights from Recent Options Trades

Upon further examination of these options trades, the data reveals that only 30% of traders maintain a bullish outlook. In contrast, 53% appear to lean towards a bearish sentiment, suggesting a trend in expectations that could influence future market activity. Out of the trades analyzed, 9 were puts collectively valued at $314,201, while 34 calls reached a total value of $3,286,532, highlighting the preference of significant financial players in this unpredictable market.

Predicted Price Range for AMZN

The analysis of volume and open interest in these options contracts suggests that large investors are targeting a price window between $175.0 and $300.0 for Amazon.com over the past quarter. This range encapsulates a critical area for traders to watch, as it can heavily influence investment strategies moving forward.

Understanding Volume & Open Interest

Volume and open interest are pivotal indicators in options trading, serving as powerful tools for assessing liquidity and trader interest. Exploring the recent data on AMZN options helps traders keep track of the evolving market behaviors and liquidity for specific strike prices. Within the last 30 days, the evolution of volume and open interest surrounding both calls and puts for AMZN has been noteworthy.

Snapshot of Amazon.com's Options Activity

Over the last month, the options market for Amazon.com has been remarkably active. Notably, several large trades have indicated specific sentiments among traders, including both bullish and bearish positions reflecting the market’s anxiety about future performance. The activity has shown a wide sentiment split, underscoring the uncertainty characterizing the current state of trading for AMZN.

Notable Options Transactions

Several significant options trades have been highlighted in recent transactions for Amazon, indicating varying sentiments:

  • AMZN CALL - $51.85 (Bearish sentiment)
  • AMZN CALL - $4.7 (Bullish sentiment)
  • AMZN CALL - $40.5 (Bearish sentiment)
  • AMZN CALL - $22.3 (Neutral sentiment)
  • AMZN CALL - $10.4 (Bullish sentiment)

About Amazon.com

Amazon is recognized as the foremost online retailer, providing a vast marketplace for third-party sellers. Approximately 75% of its revenue comes from retail, followed by Amazon Web Services, which generates about 15%. Advertising services contribute another 5% to 10%. Moreover, international sales make up 25% to 30% of Amazon's non-AWS revenues, with notable performance in key regions including Germany, the UK, and Japan.

Current Standing of Amazon.com

At present, AMZN is experiencing a trading volume of 10,150,020, with a current price of $230.89 having suffered a decline of 0.82%. The relative strength index (RSI) indicates that the stock may be nearing an overbought condition. Furthermore, stakeholders are eagerly anticipating the upcoming earnings report scheduled shortly, which could provide further insights into the company's health.

Expert Predictions on Amazon.com

Insights from five industry analysts have converged around an average target price of $263.0 for Amazon over this past month. A detailed look into their evaluations reveals:

  • A Morgan Stanley analyst maintains an Overweight rating, setting a price target of $300.
  • Piper Sandler continues to hold an Overweight rating, expecting a price of $250.
  • Telsey Advisory Group has reaffirmed their Outperform rating, suggesting a price target of $235.
  • Cantor Fitzgerald also maintains an Overweight rating with a price estimate of $260.
  • BMO Capital keeps an Outperform rating, eyeing a price of $270.

It’s important to note that while engaging in options trading, there are inherent risks with the potential for higher returns. Investors looking to navigate this complex environment often rely on ongoing education, strategic adjustments, and various indicators to keep themselves informed and prepared.

Frequently Asked Questions

What is the sentiment trend for Amazon.com's options?

A bearish sentiment dominates with 53% of traders leaning this way compared to only 30% being bullish.

What is the predicted price range for AMZN?

The expected price range for AMZN is between $175.0 and $300.0 based on observed options trading behavior.

How significant are the recent options trades for AMZN?

There have been 43 unusual trades, indicating noteworthy activity and market sentiment changes regarding AMZN.

What is the current trading status of AMZN?

AMZN is currently trading at $230.89 and has experienced a 0.82% decline in price.

What do analysts predict for Amazon.com's future performance?

Analysts suggest an average target price of $263.0, with a range of ratings indicating general confidence in Amazon's market position.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 4

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Mouser Electronics Invites Engineers to Innovation Showcase

Updated Category News Views 56

Mouser Electronics planned to make waves at the Embedded World North America 2024, taking place from October 8 to 10. This inaugural event aimed to gather the crème de la crème of the embedded community under one roof, offering a fertile ground for innovation and knowledge exchange. Mouser's Showcase: What to Expect? With industry experts set to share insights through...

Continue Reading
Exploring the Growth Potential of the Exosome Research Market

Updated Category News Views 165

Exploring the Exosome Research Market Trends The global exosome research market is on an impressive trajectory, with projections estimating its value to reach around USD 961.41 million in the next decade. The growth is attributed to a staggering compound annual growth rate (CAGR) of approximately 17.47% during the period from 2025 to 2034. In 2024, the market was valued...

Continue Reading
Vivakor Engages in $3.5 Million Stock Offer for Growth

Updated Category News Views 145

Vivakor Engages in $3.5 Million Stock Offer for Growth Vivakor, Inc. (NASDAQ: VIVK), a company specializing in integrated energy infrastructure and environmental services, has recently announced a significant move in its financing strategy. This announcement involves a registered direct offering, through which the company anticipates raising approximately $3.5 million....

Continue Reading
BlackRock TCP Capital Corp. Gets Credit Ratings Boost

Updated Category News Views 115

In the gritty world of finance, ratings can make or break a company’s standing in the eyes of investors. Recently, BlackRock TCP Capital Corp. (NASDAQ: TCPC) snagged a much-coveted upgrade from Kroll Bond Rating Agency (KBRA), signaling robust operational health intertwined with strategic smarts. The new issuer and senior unsecured debt ratings of BBB- come laced with a...

Continue Reading
Investor Sentiment Shifts Amid Oil Price Concerns for ExxonMobil

Updated Category News Views 140

Falling Oil Prices Put Pressure on ExxonMobil ExxonMobil (NYSE: XOM) slipped 3.1% in a choppy trading session, giving back not only today’s gains but part of yesterday’s progress as well. The company’s share price often moves with crude, and this time that link is clear. What’s different now is that broader market forces are piling on, amplifying the slide and...

Continue Reading